The NeufloTM System is a new non-surgical, non-thermal prostate treatment that is being developed to treat BPH. This one-time treatment is intended to be administered in your urologist's office in less than 30 minutes.
The Neuflo System uses direct current ablation technology to treat the prostate. The body creates acidic and alkaline regions within the lateral lobes of the prostate in response to the treatment. Cells within these regions are absorbed by the immune system forming voids in the lobes of the prostate, relieving pressure on the urethra.
This treatment is currently being tested in international clinical trials and is not currently available for use in the United States. A U.S. clinical trial of the Neuflo System will begin subsequent to FDA review of our IDE protocol.
For a more detailed description of the Neuflo technology, click here.